Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $2,510,705 | |
| Profit allocation | Retained in reserve capital | |
| Loans and borrowings | 1 items | |
| Capital expenditure | $9,542,943 | |
| Foreign sales | 32.72% of revenue ($71,002,398) | |
| Revenue structure | Sprzedaż produktów |
Filing timeliness
1 of 5 financial statements was filed late (for 2024, 1 day late). 4 of 5 audited by a statutory auditor.
- 202508/07/2026
- 202416/07/2025
- 202310/07/2024
- 202204/07/2023
- 202102/03/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Self-care products
- Over-the-counter medicines
- Vitamins
- Dietary supplements
Website technology
- Analytics and marketing
- Google Tag Manager
Trademarks
Opella Healthcare Poland holds 7 active trademarks registered with the Polish Patent Office. 7 marks have expired or were not registered. The first mark was filed in 2001.
| Mark | Protected until | |
|---|---|---|
| NEPENTES | Jun 11, 2034 | |
| Propolki. Gardło pod ochroną(word) | Jan 10, 2031 | |
| PROPOLIS STAMFI NATURA WSPARTA NAUKĄ | Sep 8, 2029 | |
| PROPOLIS STAMFI NATURA WSPARTA NAUKĄ CHRYPKA PODRAŻNIONE GARDŁO SUCHA ŚLUZÓWKA Propolis STAMFI + Vitaminum C PROPOLKI pastylki do ssania z propolisem STAMFI i witaminą C | Sep 8, 2029 | |
| Mark without a word element(figurative) | Jan 25, 2027 |
Authorized Representatives
Manner of representation
To make declarations and sign on behalf of the company, each member of the management board acting independently is authorized.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Opella Healthcare Participations B.v. | 32,555,668 | $439,703,781.74 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-11-19.
16 1050 0086 1000 0090 3226 7727- 57 1050 0086 1000 0090 8114 0148
- 25 1050 0086 1000 0090 8113 2285
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $664.4K$664,445 |
Buildings and premises | $11.2M$11,183,023 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 9, 2022 | Merger registered | |
| Nov 4, 2021 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medtronic Polandsp. z o.o. | $352,436,994.25 | medtronic-diabetes.com | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Berlin-Chemie / Menarini Polskasp. z o.o. | $240,194,615.27 | berlin-chemie.pl | ||
| Bristol-Myers Squibb Polskasp. z o.o. | $230,722,737.87 | bms.com | ||
| Takeda Pharmasp. z o.o. | $246,400,594.27 | takeda.com | ||
| Natur Produkt Zdrovitsp. z o.o. | $205,379,396.79 | zdrovit.pl | ||
| Astellas Pharmasp. z o.o. | $220,199,081.58 | astellas.com | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-05-23 | Address change (Ul. Bonifraterska 17, 00-203, Warszawa → Ul. Marcina Kasprzaka 6, 01-211, Warszawa) | |
| 2022-03-01 | Share capital increase (150,000.00 PLN → 1,627,783,400.00 PLN) | |
| 2020-09-22 | Entered in the register |
FAQ
Last updated: 2026-10-07